• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种治疗难治性高血压的方法。初步比较性干预措施。

, a Treatment for Uncontrolled Hypertension. Pilot Comparative Intervention.

作者信息

Al-Anbaki Marwah, Cavin Anne-Laure, Nogueira Renata Campos, Taslimi Jaafar, Ali Hayder, Najem Mohammed, Shukur Mahmood Mustafa, Abdullah Khaleel Ibrahim, Saad Mohammed Abdulqader, Ramadhan Hasan Hasan, Marcourt Laurence, Félix Fabien, Vinh Tri Low-Der's Nicolas, Ferreira Queiroz Emerson, Wolfender Jean-Luc, Watissée Marie, Graz Bertrand

机构信息

Antenna Foundation, Avenue de la Grenade 24, 1207 Geneva, Switzerland.

The Iraq Health Access Organization ("IHAO"), District 901, Abu Nawas ST, Baghdad, Iraq.

出版信息

Plants (Basel). 2021 May 19;10(5):1018. doi: 10.3390/plants10051018.

DOI:10.3390/plants10051018
PMID:34069702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8160910/
Abstract

In Iraq, in 2019, there were about 1.4 million Internally Displaced Persons (IDP); medical treatments were often interrupted. The feasibility of using () decoction to curb hypertension was evaluated. A multicentric comparative pilot intervention for 121 participants with high blood pressure (BP) (≥140/90 mmHg) was conducted. Participants of the intervention group (with or without conventional medication) received decoction on a dose regimen starting from 10 grams per day. BP was measured five times over six weeks. The major active substances were chemically quantified. Results: After 6 weeks, 61.8% of participants from the intervention group ( = 76) reached the target BP < 140/90 mmHg, compared to 6.7% in the control group ( = 45). In the intervention group, a mean (±SD) reduction of 23.1 (±11.8) mmHg and 12.0 (±11.2) for systolic and diastolic BP, respectively, was observed, while in the control group the reduction was 4.4 (±10.2)/3.6 (±8.7). The chemical analysis of the starting dose indicated a content of 36 mg of total anthocyanins and 2.13 g of hibiscus acid. The study shows the feasibility of using HS decoction in IDP's problematic framework, as hibiscus is a safe, local, affordable, and culturally accepted food product.

摘要

2019年,伊拉克约有140万国内流离失所者;医疗救治常常中断。对使用()汤剂控制高血压的可行性进行了评估。对121名高血压(BP)(≥140/90 mmHg)患者开展了一项多中心比较性试点干预。干预组参与者(无论是否使用常规药物)按照从每天10克开始的剂量方案服用汤剂。在六周内测量了五次血压。对主要活性物质进行了化学定量分析。结果:六周后,干预组61.8%的参与者( = 76)血压达到<140/90 mmHg的目标,而对照组这一比例为6.7%( = 45)。在干预组,收缩压和舒张压平均(±标准差)分别降低了23.1(±11.8)mmHg和12.0(±11.2)mmHg,而对照组的降低幅度为4.4(±10.2)/3.6(±8.7)。起始剂量的化学分析表明总花青素含量为36毫克,木槿酸含量为2.13克。该研究表明,在国内流离失所者的问题背景下使用木槿汤剂是可行的,因为木槿是一种安全、本地可得、价格低廉且在文化上可接受的食品。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f7/8160910/b4a87f7c4569/plants-10-01018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f7/8160910/f0f9cfa1f60c/plants-10-01018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f7/8160910/e460995c073b/plants-10-01018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f7/8160910/f6514d42be56/plants-10-01018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f7/8160910/b4a87f7c4569/plants-10-01018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f7/8160910/f0f9cfa1f60c/plants-10-01018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f7/8160910/e460995c073b/plants-10-01018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f7/8160910/f6514d42be56/plants-10-01018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f7/8160910/b4a87f7c4569/plants-10-01018-g004.jpg

相似文献

1
, a Treatment for Uncontrolled Hypertension. Pilot Comparative Intervention.一种治疗难治性高血压的方法。初步比较性干预措施。
Plants (Basel). 2021 May 19;10(5):1018. doi: 10.3390/plants10051018.
2
Treating Uncontrolled Hypertension with When Standard Treatment Is Insufficient: Pilot Intervention.治疗标准治疗不足的未控制高血压:先导干预。
J Altern Complement Med. 2019 Dec;25(12):1200-1205. doi: 10.1089/acm.2019.0220. Epub 2019 Oct 10.
3
Chronic administration of aqueous extract of Hibiscus sabdariffa attenuates hypertension and reverses cardiac hypertrophy in 2K-1C hypertensive rats.长期给予玫瑰茄水提取物可减轻2K-1C高血压大鼠的高血压并逆转心脏肥大。
J Ethnopharmacol. 2003 Jun;86(2-3):181-5. doi: 10.1016/s0378-8741(03)00078-3.
4
Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial.玫瑰茄标准化提取物对轻至中度高血压患者的有效性和耐受性:一项对照随机临床试验。
Phytomedicine. 2004 Jul;11(5):375-82. doi: 10.1016/j.phymed.2004.04.001.
5
Long-term ingestion of Hibiscus sabdariffa calyx extract enhances myocardial capillarization in the spontaneously hypertensive rat.长期摄入玫瑰茄花萼提取物可增强自发性高血压大鼠的心肌毛细血管化。
Exp Biol Med (Maywood). 2012 May;237(5):563-9. doi: 10.1258/ebm.2012.011357.
6
Hypertension treatment with Combretum micranthum or Hibiscus sabdariffa, as decoction or tablet: a randomized clinical trial.用宽叶金锦香或洛神花进行高血压治疗,无论是汤剂还是片剂:一项随机临床试验。
J Hum Hypertens. 2021 Sep;35(9):800-808. doi: 10.1038/s41371-020-00415-1. Epub 2020 Sep 18.
7
Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: a systematic review and meta-analysis of randomized controlled trials.酸茶(玫瑰茄)对动脉高血压的影响:随机对照试验的系统评价和荟萃分析
J Hypertens. 2015 Jun;33(6):1119-27. doi: 10.1097/HJH.0000000000000585.
8
Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial.一种标准化木槿属药用产品对高血压患者的临床疗效。一项随机、双盲、赖诺普利对照的临床试验。
Planta Med. 2007 Jan;73(1):6-12. doi: 10.1055/s-2006-957065.
9
A systematic review and meta-analysis of the effects of Hibiscus sabdariffa on blood pressure and cardiometabolic markers.系统评价和荟萃分析小豆蔻红对血压和心脏代谢标志物的影响。
Nutr Rev. 2022 May 9;80(6):1723-1737. doi: 10.1093/nutrit/nuab104.
10
Effect of Hibiscus sabdariffaon blood pressure and electrolyte profile of mild to moderate hypertensive Nigerians: A comparative study with hydrochlorothiazide.玫瑰茄对轻度至中度高血压尼日利亚人的血压和电解质状况的影响:与氢氯噻嗪的比较研究
Niger J Clin Pract. 2015 Nov-Dec;18(6):762-70. doi: 10.4103/1119-3077.163278.

引用本文的文献

1
Exploring the Health Benefits and Therapeutic Potential of Roselle (Hibiscus sabdariffa) in Human Studies: A Comprehensive Review.探索玫瑰茄(木槿属)在人体研究中的健康益处和治疗潜力:一项综合综述。
Cureus. 2023 Nov 23;15(11):e49309. doi: 10.7759/cureus.49309. eCollection 2023 Nov.
2
Physiological Effects and Human Health Benefits of : A Review of Clinical Trials.《[具体内容]的生理效应及对人类健康的益处:临床试验综述》 (因原文冒号前内容缺失,只能给出大概形式,需补充完整原文冒号前内容才能准确翻译)
Pharmaceuticals (Basel). 2022 Apr 12;15(4):464. doi: 10.3390/ph15040464.
3
Nephroprotective Plants: A Review on the Use in Pre-Renal and Post-Renal Diseases.

本文引用的文献

1
A systematic review of the burden of hypertension, access to services and patient views of hypertension in humanitarian crisis settings.在人道主义危机环境中,对高血压的负担、服务获取情况以及患者对高血压看法的系统评价。
BMJ Glob Health. 2020 Nov;5(11). doi: 10.1136/bmjgh-2020-002440.
2
Hypertension treatment with Combretum micranthum or Hibiscus sabdariffa, as decoction or tablet: a randomized clinical trial.用宽叶金锦香或洛神花进行高血压治疗,无论是汤剂还是片剂:一项随机临床试验。
J Hum Hypertens. 2021 Sep;35(9):800-808. doi: 10.1038/s41371-020-00415-1. Epub 2020 Sep 18.
3
The efficacy of sour tea (Hibiscus sabdariffa L.) on selected cardiovascular disease risk factors: A systematic review and meta-analysis of randomized clinical trials.
肾保护植物:肾前性和肾后性疾病应用综述
Plants (Basel). 2022 Mar 18;11(6):818. doi: 10.3390/plants11060818.
4
Roselle for hypertension in adults.洛神花治疗成人高血压。
Cochrane Database Syst Rev. 2021 Nov 27;11(11):CD007894. doi: 10.1002/14651858.CD007894.pub3.
5
Roselle for hypertension in adults.玫瑰茄用于成人高血压。
Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD007894. doi: 10.1002/14651858.CD007894.pub2.
酸茶(洛神花)对部分心血管疾病风险因素的功效:随机临床试验的系统评价和荟萃分析。
Phytother Res. 2020 Feb;34(2):329-339. doi: 10.1002/ptr.6541. Epub 2020 Jan 14.
4
Treating Uncontrolled Hypertension with When Standard Treatment Is Insufficient: Pilot Intervention.治疗标准治疗不足的未控制高血压:先导干预。
J Altern Complement Med. 2019 Dec;25(12):1200-1205. doi: 10.1089/acm.2019.0220. Epub 2019 Oct 10.
5
Effect of hibiscus sabdariffa on blood pressure in patients with stage 1 hypertension.玫瑰茄对1期高血压患者血压的影响。
J Adv Pharm Technol Res. 2019 Jul-Sep;10(3):107-111. doi: 10.4103/japtr.JAPTR_402_18.
6
Hibiscus acid from Hibiscus sabdariffa (Malvaceae) has a vasorelaxant effect on the rat aorta.鸡冠花酸(锦葵科鸡冠花)对大鼠主动脉具有血管舒张作用。
Fitoterapia. 2019 Apr;134:5-13. doi: 10.1016/j.fitote.2019.01.012. Epub 2019 Jan 25.
7
2018 ESC/ESH Guidelines for the management of arterial hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南。
Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.
8
A review on phytochemistry and therapeutic uses of Hibiscus sabdariffa L.关于洛神花(Hibiscus sabdariffa L.)的植物化学和治疗用途的综述
Biomed Pharmacother. 2018 Jun;102:575-586. doi: 10.1016/j.biopha.2018.03.023. Epub 2018 Apr 5.
9
Crystal structures of hibiscus acid and hibiscus acid dimethyl ester isolated from (Malvaceae).从锦葵科植物中分离得到的芙蓉酸和芙蓉酸二甲酯的晶体结构。
Acta Crystallogr E Crystallogr Commun. 2017 Aug 21;73(Pt 9):1368-1371. doi: 10.1107/S2056989017011902. eCollection 2017 Sep 1.
10
Hibiscus sabdariffa L., roselle calyx, from ethnobotany to pharmacology.玫瑰茄(Hibiscus sabdariffa L.),玫瑰茄花萼,从民族植物学到药理学
J Exp Pharmacol. 2012 Feb 28;4:25-39. doi: 10.2147/JEP.S27974. eCollection 2012.